Sales & Marketing Evolving HCP access requires a new connected approach to bui... Specialty medicines – treatments designed for very small patient populations with complex and rare conditions – are on the rise.
Digital Sponsored How to deal with fragmented data - A $12.9 million challenge In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D Partner Content LEAP HR: Emerging Biopharma Lead The Future in Emerging Biopharma: Revolutionize Your HR Strategy, Develop Top Talent & Empower Your Team to Secure Success Amidst Industry Turbul
Digital Driving growth with connected health Connected health stands at the intersection of healthcare and technology, where innovation is reshaping patient care.
Sales & Marketing Minutes to answers: Compliant chat builds more meaningful HC... As therapies become more complex, field reps and doctors are finding new ways to create purposeful interactions in the time of need.
Market Access Applying intercultural intelligence to promote growth in the... There are significant opportunities for pharma and biotech companies to support patients in the Middle East, but how do companies navigate such a culturally diverse region?
News GSK plans $800m US manufacturing investment GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.